{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Toxoplamosis", "new drugs", "phytotherapy", "plant extract", "protozoan", "toxicity"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38952156", "DateRevised": {"Year": "2024", "Month": "07", "Day": "02"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0115680266299409240606062235"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "28"}], "Journal": {"ISSN": "1873-4294", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Jun", "Day": "28"}}, "Title": "Current topics in medicinal chemistry", "ISOAbbreviation": "Curr Top Med Chem"}, "ArticleTitle": "The Search for Drugs Derived from Natural Products for Toxoplasma gondii Infection Treatment in the Last 20 Years - A Systematic Review.", "Abstract": {"AbstractText": ["Toxoplasmosis is a worldwide distributed zoonosis caused by Toxo-plasma gondii (T. gondii), an obligate intracellular protozoan. The infection in immunocompetent hosts usually progresses with mild or no symptoms. However, in immunocompromised individu-als, this disease can cause severe or fatal symptoms.", "Sulfadiazine and pyrimethamine are two drugs used as standard therapies for human toxoplasmosis. Although they do not cause chronic infection, they may cause hematological tox-icity, hypersensitivity, intolerance, teratogenic effects, gastrointestinal disorders, and bone mar-row suppression.", "The limited effect, significant toxicity, and emerging resistance to current drugs available to treat T. gondii infections require investigating other effective, nontoxic, and well-tolerated al-ternatives. Medicinal plants are, traditionally, the most promising sources used to treat infectious diseases.", "This review provides data on new therapeutic and prophylactic methods for T. gondii infection based on the use of extracts and/or compounds derived from natural products, which have been reported to be useful as alternative treatment options in the last 20 years."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Funda\u00e7\u00e3oOswaldo Cruz - Fiocruz, Instituto Oswaldo Cruz, Laborat\u00f3rio de Toxoplasmose e outras Protozooses, Rio de Janeiro, RJ, Brasil."}], "LastName": "Marques-Santos", "ForeName": "Fabielle", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Oswaldo Cruz, Laborat\u00f3rio de Avalia\u00e7\u00e3o e Promo\u00e7\u00e3o da Sa\u00fade Ambiental, Rio de Janeiro, RJ, Brasil."}], "LastName": "Faria", "ForeName": "Robson Xavier", "Initials": "RX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Funda\u00e7\u00e3oOswaldo Cruz - Fiocruz, Instituto Oswaldo Cruz, Laborat\u00f3rio de Toxoplasmose e outras Protozooses, Rio de Janeiro, RJ, Brasil."}], "LastName": "Amendoeira", "ForeName": "Maria Regina Reis", "Initials": "MRR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Top Med Chem", "NlmUniqueID": "101119673", "ISSNLinking": "1568-0266"}}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2024", "Month": "1", "Day": "24"}, {"Year": "2024", "Month": "3", "Day": "25"}, {"Year": "2024", "Month": "3", "Day": "28"}, {"Year": "2024", "Month": "7", "Day": "2", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "2", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "2", "Hour": "2", "Minute": "33"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38952156", "10.2174/0115680266299409240606062235", "CTMC-EPUB-141348"]}}]}